Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers

Many epithelial cancers rely on enhanced expression of the epidermal growth factor receptor (EGFR) to drive proliferation and survival pathways. Development of therapeutics to target EGFR signaling has been of high importance, and multiple examples have been approved for human use. However, many of...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Nathan, FitzGerald, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885052/
https://www.ncbi.nlm.nih.gov/pubmed/27153091
http://dx.doi.org/10.3390/toxins8050137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885052/
https://www.ncbi.nlm.nih.gov/pubmed/27153091
http://dx.doi.org/10.3390/toxins8050137

Ejemplares similares